广发证券日前报告指,财险景气度向好,人身险经营质态改善。中国人保H股估值长期低于中国财险,认为当下中国人保具备相对投资价值:一是财险景气度回升下中国人保H股相对中国财险便宜;二是人保寿险价值转型和监管支持下经营质态持续改善;三是人保健康成长性凸显,市场份额位居健康险子公司和互联网健康险前列,赔付率改善驱动利润和价值高增。分部估值法A/H合理价值为11.29元/股和8.22港元/股,给予“买入”评级...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.